AT
NVS icon

Adelphi Trust’s Novartis NVS Stock Holding History

Adelphi Trust’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$249K Buy
1,749
+116
+7% +$17.6K 0.16% 102
2026
Q2 		$256K Buy
1,633
+233
+17% +$34.9K 0.17% 101
2026
Q1 		$214K Sell
1,400
-115
-8% -$17.6K 0.17% 101
2025
Q4 		$209K Buy
+1,515
New +$198K 0.17% 96

Other funds holding NVS

FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
CT
Coastline Trust Providence, Rhode Island $1.07B AUM 21.73% 1-Year Est. Return
PNC
Park National Corp Newark, Ohio $3.69B AUM 18.32% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
KGC
Kennon-Green & Company New Albany, Ohio $131M AUM 8.08% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
MAM
Marotta Asset Management Charlottesville, Virginia $589M AUM 14.57% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return
BTWM
Baker Tilly Wealth Management Madison, Wisconsin $510M AUM 18.32% 1-Year Est. Return
VCM
Violich Capital Management San Francisco, California $927M AUM 28.93% 1-Year Est. Return

Adelphi Trust's NVS Position: Q3 2026 in Review

Adelphi Trust increased its Novartis (NVS) stake by 7.1% in Q3 2026, buying an estimated $17.6K and bringing the position to 1,749 shares worth $249K. The position accounts for 0.16% of the portfolio, ranked #102.

Adelphi Trust first reported a position in NVS in Q4 2025 and has held it in 4 quarters since. The position peaked at $256K in Q2 2026. 20 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Adelphi Trust held 1,749 shares of Novartis worth $249K as of Q3 2026.
  • Adelphi Trust bought 116 Novartis shares in Q3 2026, an estimated $17.6K.
  • Novartis made up 0.16% of Adelphi Trust's portfolio in Q3 2026, its #102 holding.
  • Adelphi Trust first reported a position in Novartis in Q4 2025 and has held it in 4 quarters since.
  • Adelphi Trust's Novartis position peaked at $256K in Q2 2026.
  • 20 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Adelphi Trust's 13F filing for Q3 2026, filed 5 Oct 2026.